EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

New criteria to predict LATE-NC in the clinical setting: Probable/Possible LATE and LANS

Peter T Nelson iD

Journal of Neuropathology & Experimental Neurology · 01.01.2025 · 84 (1) · 2-7

DOI: 10.1093/jnen/nlae113 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neuropathology & Experimental Neurology, online erschienen am 23.10.2024. Verfasst von Peter T Nelson. Beteiligte Einrichtung: Sanders-Brown Center on Aging, Division of Neuropathology, Department of Pathology, University of Kentucky, Lexington, KY 40536, United States. Hauptthemen laut MEDLINE: TDP-43 Proteinopathies. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review discusses terminology recently proposed for the classification of dementia and, more specifically, nosology related to aging-associated TDP-43 pathology: limbic-predominant age-related TDP-43 encephalopathy (LATE), and limbic-predominant amnestic neurodegenerative syndrome (LANS). While the “gold standard” for these clinical conditions is still LATE neuropathologic changes (LATE-NC), clinical criteria and biomarkers are evolving. The newly proposed clinical rubrics are discussed with emphasis on the need for terminology that acknowledges the distinctions between clinical syndrome-, molecular biomarker-, and pathologically defined disease concepts. As further progress is made on research into the specific biomarker-based detection and prediction of TDP-43 proteinopathy in the clinical setting, the definitions of “Probable” and “Possible” LATE are likely to become more useful clinically. For people interested in the pathological diagnoses or basic research related to LATE-NC, the relevant terminology remains unchanged by the newly proposed clinical criteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TDP-43 ProteinopathiesHumansDementiaNeurodegenerative DiseasesAmnesiaAgingBiomarkers

Stichwörter der Autor:innen

Alzheimer disease and related dementia (ADRD)FDG-PETLATE-NCTDP-43amnesiabiomarkerdementia

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Sanders-Brown Center on Aging, Division of Neuropathology, Department of Pathology, University of Kentucky, Lexington, KY 40536, United States.

ORCID-Profile: Peter T Nelson

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Nelson, P. T. (2025). New criteria to predict LATE-NC in the clinical setting: Probable/Possible LATE and LANS. Journal of Neuropathology & Experimental Neurology, 84(1), 2-7. https://doi.org/10.1093/jnen/nlae113

Vancouver

Nelson PT. New criteria to predict LATE-NC in the clinical setting: Probable/Possible LATE and LANS. Journal of Neuropathology & Experimental Neurology. 2025;84(1):2-7. doi:10.1093/jnen/nlae113

BibTeX
@article{Nelson2025,
  author = {Nelson, Peter T},
  title = {New criteria to predict LATE-NC in the clinical setting: Probable/Possible LATE and LANS},
  journal = {Journal of Neuropathology & Experimental Neurology},
  year = {2025},
  volume = {84},
  number = {1},
  pages = {2--7},
  doi = {10.1093/jnen/nlae113}
}
Kostenlos starten →